Cascadian Therapeutics, Inc. Total Assets
Cascadian Therapeutics, Inc. had Total Assets of $120.83 million as of 2017-12-31, per its 10-K filed 2018-03-08.
Discontinued › Balance Sheet › Assets
us-gaap:Assets · last filed 2018-03-08
- 2017-12-31: Assets $120.83M.
- 2017-09-30: Assets $133.39M.
- 2017-06-30: Assets $145.51M.
- 2017-03-31: Assets $157.17M.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2017-12-31 | $120.83M 10-K · filed 2018-03-08 | |
| 2017-09-30 | $133.39M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $145.51M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $157.17M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $83.27M 10-K · filed 2018-03-08 | |
| 2016-09-30 | $91.83M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $100.83M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $87.13M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $96.57M 10-K · filed 2017-03-09 | |
| 2015-09-30 | $103.23M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $109.58M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $117.34M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $103.10M 10-K · filed 2016-03-14 | $103.41M 10-K · filed 2015-03-10 |
| 2014-09-30 | $130.95M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $63.57M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $69.69M 10-Q · filed 2014-05-01 | |
| 2013-12-31 | $77.75M 10-K · filed 2015-03-10 | |
| 2013-09-30 | $79.23M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $74.88M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $82.27M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $89.44M 10-K · filed 2014-03-13 | |
| 2012-09-30 | $97.09M 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $103.52M 10-Q · filed 2012-08-13 | |
| 2012-03-31 | $64.85M 10-Q/A · filed 2012-08-13 | |
| 2011-12-31 | $71.54M 10-K · filed 2013-03-14 | $71.35M 10-K · filed 2012-03-09 |
| 2011-09-30 | $67.56M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $71.80M 10-Q · filed 2011-08-08 | |
| 2010-12-31 | $34.45M 10-K/A · filed 2012-08-13 |